Trimodality Protocol for the Treatment of Locally Advanced, Potentially Resectable Non-Small Cell Lung Cancer Targeting.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Carboplatin; Paclitaxel
- Indications Non-small cell lung cancer
- Focus Adverse reactions
- 15 Feb 2021 Biomarkers information updated
- 23 May 2007 Status changed from recruiting to in progress.
- 09 Aug 2005 New trial record.